Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund | ETW | Nov 27, 2024 | 8.50 | +0.35 |
Eaton Vance Tax-Managed Global Diversified Equity Income Fun | EXG | Nov 27, 2024 | 8.35 | +0.12 |
Eaton Vance Taxmanaged Buywrite Income Fund | ETB | Nov 27, 2024 | 14.93 | -0.07 |
Ebang International A | EBON | Nov 27, 2024 | 7.45 | +2.19 |
eBay | EBAY | Nov 27, 2024 | 64.31 | -1.20 |
Ecarx A | ECX | Nov 27, 2024 | 1.86 | -1.06 |
ECB Bank | ECBK | Nov 27, 2024 | 14.79 | -0.74 |
ECD Automotive Design | ECDA | Nov 27, 2024 | 0.97 | -1.02 |
EchoStar | SATS | Nov 27, 2024 | 25.03 | +0.64 |
Eco Wave Power Global ADR | WAVE | Nov 27, 2024 | 9.82 | -15.42 |
EcoLab | ECL | Nov 27, 2024 | 247.70 | +0.13 |
Ecopetrol ADR | EC | Nov 27, 2024 | 8.04 | +0.75 |
Ecovyst | ECVT | Nov 27, 2024 | 7.95 | -0.63 |
EDAP TMS ADR | EDAP | Nov 27, 2024 | 2.41 | +1.69 |
Edesa Biotech | EDSA | Nov 27, 2024 | 2.30 | +4.07 |
Edgewell Personal Care | EPC | Nov 27, 2024 | 36.70 | -0.73 |
Edgewise Therapeutics | EWTX | Nov 27, 2024 | 32.20 | +0.37 |
Edgio | EGIO | Nov 27, 2024 | 1.38 | 0.00 |
Edible Garden | EDBL | Nov 27, 2024 | 0.17 | +8.02 |
Edison International | EIX | Nov 27, 2024 | 88.36 | +0.71 |
Editas Medicine | EDIT | Nov 27, 2024 | 2.20 | -0.45 |
Educational Development | EDUC | Nov 27, 2024 | 1.88 | +0.53 |
Edwards Lifesciences | EW | Nov 27, 2024 | 72.07 | +0.73 |
eFFECTOR Therapeutics | EFTR | Nov 27, 2024 | 0.18 | 0.00 |
eGain | EGAN | Nov 27, 2024 | 5.13 | -2.10 |
EHang ADR | EH | Nov 27, 2024 | 14.99 | +2.39 |
eHealth | EHTH | Nov 27, 2024 | 5.50 | +2.42 |
Eightco | OCTO | Nov 27, 2024 | 1.89 | +5.00 |
Ekso Bionics | EKSO | Nov 27, 2024 | 0.66 | -1.22 |
El Paso Pref | EP-C | Nov 27, 2024 | 48.36 | +0.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.